RecruitingNCT06347276

Cerebral Microembolization Associated With PFO Closure

De Novo Cerebral Microembolization Associated With Patent Foramen Ovale Closure

Sponsor

China National Center for Cardiovascular Diseases

Enrollment

800 participants

Start Date

Jan 1, 2024

Study Type

OBSERVATIONAL

Conditions

Atrial Septal Defect Patent Foramen Ovale (PFO)Thrombosis Cardiac

Summary

This study aims to investigate (1) the de novo cerebral microembolization in patients who undergo transcatheter closure of PFO or ASD, and (2) evaluate the relationship between de novo cerebral microembolization and in situ thrombus within PFO.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called PFO occluder; ASD occluder for people with atrial septal defect, patent foramen ovale (pfo), and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPFO occluder; ASD occluder

Transcatheter closure of atrial septal defect (ASD) and patent foramen ovale (PFO) All cases will be examined with DW-MRI preoperatively, and DW-MRI will be repeated 24 hours and 4 weeks after the transcatheter closure procedure.